Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 22, 2025 4
4 May 22, 2025 4
4 May 22, 2025 4
4 May 22, 2025 4
4 May 22, 2025 4
4 May 22, 2025 4
3 May 22, 2025 3
8-K May 22, 2025 8-K
SCHEDULE 13G/A May 15, 2025
SCHEDULE 13G/A May 15, 2025
SCHEDULE 13G May 15, 2025
10-Q May 12, 2025 10-Q
8-K May 12, 2025 8-K
SCHEDULE 13G/A May 12, 2025
SCHEDULE 13G/A Apr 24, 2025
SCHEDULE 13G Apr 17, 2025
ARS Apr 10, 2025 ARS
DEFA14A Apr 10, 2025 DEFA14A
DEF 14A Apr 10, 2025 DEF 14A
SCHEDULE 13G Mar 24, 2025
SCHEDULE 13D/A Mar 19, 2025
S-8 Mar 11, 2025 S-8
10-K Mar 11, 2025 10-K
8-K Mar 11, 2025 8-K
4 Mar 5, 2025 4
← Newer Page 6 of 27 · 660 filings Older →